Efficacy News and Research

RSS
Carotid artery stenting increases risk of death, stroke

Carotid artery stenting increases risk of death, stroke

Combination therapy for ovarian cancer leads to greater toxicity

Combination therapy for ovarian cancer leads to greater toxicity

HHS awards $5 million grant to support teen pregnancy prevention programs

HHS awards $5 million grant to support teen pregnancy prevention programs

Phase 3 study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors

Phase 3 study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors

Early cancer drug trials flawed by inconsistencies in prohibited drug lists, study finds

Early cancer drug trials flawed by inconsistencies in prohibited drug lists, study finds

Embryonic stem cells used in first trial for spinal cord injury

Embryonic stem cells used in first trial for spinal cord injury

CTCA in Tulsa purchases BSD-2000 Hyperthermia System

CTCA in Tulsa purchases BSD-2000 Hyperthermia System

Gelesis presents lead products data at Obesity 2010 Annual Meeting

Gelesis presents lead products data at Obesity 2010 Annual Meeting

MingSight acquires worldwide rights from Pfizer to develop new chemical entities for human diseases

MingSight acquires worldwide rights from Pfizer to develop new chemical entities for human diseases

AVEO presents tivozanib Phase 2 study results at ESMO Congress

AVEO presents tivozanib Phase 2 study results at ESMO Congress

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer

Allos announces favorable survival data from FOLOTYN Phase 2b study

Allos announces favorable survival data from FOLOTYN Phase 2b study

MOH approves BrainStorm's NurOwn stem cell therapy for Phase I/II clinical trial

MOH approves BrainStorm's NurOwn stem cell therapy for Phase I/II clinical trial

TTF therapy with chemotherapy increases survival time in patients with non-small cell lung cancer

TTF therapy with chemotherapy increases survival time in patients with non-small cell lung cancer

Millennium, Seattle Genetics announce positive top-line results of SGN-35 phase II clinical trial

Millennium, Seattle Genetics announce positive top-line results of SGN-35 phase II clinical trial

FDA issues CRL for AZ-004 NDA application

FDA issues CRL for AZ-004 NDA application

Auxilium commences dosing in global XIAFLEX phase III program for Peyronie's disease

Auxilium commences dosing in global XIAFLEX phase III program for Peyronie's disease

Lifestyle interventions benefit overweight, obese and severely obese adults

Lifestyle interventions benefit overweight, obese and severely obese adults

University of Missouri creates National Botanical Research Center with $7.5M NIH grant

University of Missouri creates National Botanical Research Center with $7.5M NIH grant

Takeda, Envoy enter three-year research alliance to develop schizophrenia drug

Takeda, Envoy enter three-year research alliance to develop schizophrenia drug

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.